$IMA

$4.02 -$0.03 (0.74%) Close

$IMA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 11.4M shares outstanding

Who owns IMA?

By type of holder

Institutions 54.9% Insiders 25.1% Everyone else 20.0%

Concentration Top 10 holders own 69.9%

BVF Inc/il 9.8% · Orbimed Capital GP Vi LLC 9.6%

Institutional ownership

54.9%

+7.7 pts vs last qtr

Institutional holders

-4 vs last qtr

Net shares bought

+878.7K

by institutions in Q2 2026

New / sold out

4 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Orbimed Advisors LLC +530.7K
Trails Edge Capital Partners, LP NEW +282.0K

Biggest sellers in Q2 2026

Citadel Advisors LLC −68.7K
Blue Owl Capital Holdings LP −41.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for ImageneBio Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2024

+72.5%

+19.92% a year

Each share's claim on the business

−42.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$663K vs $20.3M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years49% 3–5 years1% 1–3 years21% Under 1 year28%

Quarterly turnover

12.3%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting IMA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BI BVF Inc/il	1.1M	9.78%	Unchanged	≤2021	0.2%
Shares held by quarter Peak holding4.8M (Q3'24) Change over 8 quarters−3.7M Share of the company9.780% BVF Inc/il's full portfolio →
BO Blue Owl Capital Holdings LP	917.7K	8.08%	−41.6K (−4.3%)	2023	0.8%
Shares held by quarter Peak holding4.1M (Q3'24) Change over 8 quarters−3.2M Share of the company8.080% Blue Owl Capital Holdings LP's full portfolio →

BVF Inc/il

1.1M

% of company

9.78%

Change vs last qtr

Unchanged

Held since

≤2021

Blue Owl Capital Holdings LP

917.7K

% of company

8.08%

Change vs last qtr

−41.6K (−4.3%)

Held since

2023

28 more super investors behind a free account

See every manager holding ImageneBio Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting IMA on Form N-PORT; together they hold 3.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$1.56M	264.8K	2.33%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$310K	52.5K	0.46%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$1.56M

% of company

2.33%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$310K

% of company

0.46%

% of the fund

0.00%

As of

June 30, 2026

8 more funds behind a free account

See every fund holding ImageneBio Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OC Orbimed Capital GP Vi LLC 5%+ holder 13D · 9.6%	1.1M	9.60%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company9.600% Disclosed stake13D · 9.6% View the 13D/G filing →
OF Omega Fund VI, L.P. 5%+ holder 13D · 8.4%	935.8K	8.24%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company8.240% Disclosed stake13D · 8.4% View the 13D/G filing →

Orbimed Capital GP Vi LLC

5%+ holder13D · 9.6%

1.1M

% of company

9.60%

Change vs last qtr

—

Held since

—

Omega Fund VI, L.P.

5%+ holder13D · 8.4%

935.8K

% of company

8.24%

Change vs last qtr

—

Held since

—

23 more holders behind a free account

See every insider and 5%+ holder of ImageneBio Inc.

Comments